Drug Approval | November 23, 2022
USFDA grants priority review of BLA for dengue vaccine TAK-003
If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers
If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers
He also encouraged all G20 members to contribute their public keys to the proposed Global Federated Public Trust Directory for ensuring seamless worldwide mobility of people and goods
This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
The licences will allow manufacturers from around the world to work with MPP and C-TAP to make these technologies accessible to people living in low- and middle-income countries
The report has estimated 4.74 million deaths for India in 2020 and 2021,
It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
Subscribe To Our Newsletter & Stay Updated
